The optimal management of polycythaemia vera

Br J Haematol. 2003 Feb;120(3):543-4; author reply 544-5. doi: 10.1046/j.1365-2141.2003.04112_2.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Disease Progression
  • Humans
  • Hydroxyurea / therapeutic use*
  • Nucleic Acid Synthesis Inhibitors / therapeutic use*
  • Platelet Count
  • Polycythemia Vera / drug therapy*

Substances

  • Nucleic Acid Synthesis Inhibitors
  • Hydroxyurea